153 results about "Isotonic Solutions" patented technology

The invention is further directed to producing a cleaned, disinfected, and devitalized cartilage graft by optionally cleaning and disinfecting the cartilage graft; treating the cartilage graft in a pretreatment solution; treating the cartilage graft in an extracting solution; washing the extracted cartilage graft with a rinsing solution; and subsequently soaking the devitalized cartilage graft in a storage solution. The devitalized cartilage graft is essentially free from metabolically viable and/or reproductively viable cells and the rinsing solution is hypotonic solution or isotonic solution. The present invention is further directed to a cleaned, disinfected, and devitalized cartilage graft and a process for cleaning, disinfecting, and devitalizing cartilage grafts. The invention also relates to a process for repairing a cartilage defect and implantation of a cartilage graft into a human or animal by crafting the cartilage matrix into individual grafts, disinfecting and cleaning the cartilage graft, applying a pretreatment solution to the cartilage graft, removing cellular debris using an extracting solution to produce a devitalized cartilage graft, implanting the cartilage graft into the cartilage defect with or without an insertion device, and sealing the implanted cartilage graft with recipient tissue. The devitalized cartilage graft is optionally recellularized in vitro, in vivo, or in situ with viable cells to render the tissue vital before or after the implantation. The devitalized cartilage graft is also optionally stored between the removing cellular debris and the recellularizing steps.

The field of colonic diagnostic and surgical procedures is hampered by the lack of optimal means available to cleanse the colon. A compromise between convenient, distasteful, solid or low volume, hyperosmotic solutions which cause considerable fluid and electrolyte imbalances in patients and large volume, difficult to consume, iso-osmotic solutions has had to be made heretofore. This invention describes a low volume, hyper-osmotic solution consisting of sulfate salts with and with out polyethylene glycol. Unlike prior art, this composition is useful for the cleansing of the bowel and, in lower volumes, as a laxative, without producing clinically significant changes in bodily function.

The invention relates to a cross-linked hyaluronic acid cell-scaffold material and its preparation method and application. The cross-linked hyaluronic acid cell-scaffold material is obtained by crosslinking of high-molecular hyaluronate and low-molecular hyaluronate. The proportion of hyaluronate disaccharide molecules which take part in the crosslinking is 0.5%-20%, and expansion rate of the hyaluronate disaccharide molecules in an isotonic solution is 80%-110%. The preparation method of the cell-scaffold material comprises two freeze drying steps. Hyaluronate mixed with a cross-linking agent is formed firstly; after a heating reaction, water is added for swelling to form gel; and freeze drying is then carried out to obtain the porous scaffold material. The scaffold has abundant pores, has a certain mechanical strength and pore size and has good hydroscopicity and biocompatibility. The scaffold can be used as a tissue engineering cell-scaffold in promoting cartilage injury repairing and also can be used for preparing a haemostasis anti-adhesion material.

The invention provides II-type collagen joint cartilage fluid and a preparation method thereof. Bacteria, viruses and other hazardous substances of the joint cartilage are removed through degreasing-> serum removing-> surfactant treatment-> oxidant treatment-> disinfection and other links. Hybrid protein and other denatured protein of the cartilage are removed through acid hydrolysis, salt precipitation, dialysis and other processes, and high-purity and high-activity II-type collagen solution is prepared. Non-toxin and non-heat raw materials and auxiliary materials and isotonic solution are mixed in an appropriate ratio, and filled in a sterile non-heat disposable injector, to prepare II-type collagen joint cartilage fluid for disposable injection. Other components of the II-type collagen joint cartilage fluid comprise the auxiliary materials and the isotonic solution. The II-type collagen joint cartilage fluid can play the roles of lubrication, pain relieving and joint activity degree improving to the injured joints, fundamentally realizes the internal repair to the cartilage tissue, and is applicable to a patient with various joint cartilage injuries and all types of arthritis.

The invention discloses a preparation method of a natural-tissue-derived decellularized and decalcified bone material. According to the method, any bone tissue of a mammal is treated with a protease inhibitor-containing normal saline buffer, an organic solvent, Tirton X-containing PBS (phosphate buffer saline), SDS (sodium dodecyl sulfonate)-containing PBS, pancreatin-containing PBS, deoxyribonuclease-containing PBS, an EDTA (ethylene diamine tetraacetic acid) isotonic solution and ultrasonic waves, and the decellularized and decalcified bone material is obtained. Cancellous bones and cortical bones can be decellularized completely and simultaneously, the conditions are mild, damage to an ECM (extracellular matrix) is avoided, rapidness and stability are realized, and the obtained decellularized and decalcified bone material has the advantages of good biocompatibility, high plasticity, high biomechanical strength and the like and can be used for clinically repairing bone regeneration and repair disorder such as bone defects, nonunion and the like caused by various causes.

A composition that is used as an eye treatment contains reduced glutathione, vitamin A and vitamin E, as well as one or more of zinc sulfate, boric acid and potassium as buffering agents. The composition also may contain a lubricant and a preservative. The composition is a sterile isotonic solution. The composition is used in a method of treating eyes for the alleviation of irritations and/or dryness, as well as for the prevention and treatment of cataracts.

The invention discloses a special nutritional supplement agent for preoperative patients. The nutritional supplement agent contains maltodextrin, levulose, glutamine, sodium ions and potassium ions. When the preoperative nutritional agent is taken, the nutritional agent can be compounded into an isotonic solution of which the osmotic pressure level is similar to that of plasma, so that the possibility of diarrhoea caused by that a great deal of liquid enters intestinal tracts through tissues due to osmotic pressure differences can be obviated; the feeling that an operation patient feels thirsty and tired can be obviously improved, and the symptoms of nausea, vomit, diarrhoea, abdominal distension and the like cannot be caused; complete emptying can be realized within 79-107 minutes, and experiments confirm that taking the nutritional agent for 2 hours before the operation is safe; in addition, the nutritional agent also has good effects of improving insulin resistance and maintaining intestinal mucosal barriers.

The invention discloses a kit for obtaining a multiple-organ and tissue extracellular matrix and a using method of the kit. The kit for obtaining the multiple-organ and tissue extracellular matrix comprises a nonionic detergent I, an ionic detergent I, an ionic detergent II, a hypertonic solution, a hypotonic solution, an isotonic solution, a nucleic acid removal agent and a tissue bulking agent. According to the kit and a method for using the kit provided by the invention, acellularized scaffolds of multiple organs and tissues can be obtained in a short time, and the structure and most of structure of the extracellular matrix are maintained, so that product materials are provided for research and application of regenerative medicines and tissue engineering.

A composition for treatment of bacterial infections of the eye is disclosed which comprises a lytic enzyme composition specific for the infecting bacteria, and a carrier for delivering said lytic enzyme.. The carrier for delivering at least one lytic enzyme to the eye may be but is not limited to the use of an isotonic solution..

The invention relates to a method of preparing an intra-dermally, intra-articularly, sub-dermally or topically administrable growth factor concentrate derived from human platelets. The method comprises the steps of suspending human platelets in multiple electrolyte isotonic solution; snap-freezing the suspension; thawing the frozen suspension; and sterile-filtering the suspension. In particular, in this method, a fixed number of platelets is suspended in a fixed volume of multiple electrolyte isotonic solution to obtain the required concentration of growth factors in the growth factor concentrate, snap-freezing of the suspension is carried out at a temperature of −120° C. to −200° C., thawing of the frozen suspension is carried out at 25° C. to 37° C., and cellular debris are separated from the thawed suspension and the resultant suspension of growth factors is diluted with an isotonic medium before sterile-filtering.

The invention relates to a technique for preserving erythrocytes in low temperature refrigerator for a long time. Wherein, erythrocyte frozen protective solution is of high osmotic pressure, and contains macromolecular substances with biocompatibility and DMSO (dimethyl sulfoxide). Washing solution is composed of basically isotonic solution and macromolecular substances with biocompatibility. Frozen stock solution can make the erythrocytes go into the hypertonic condition without severe hemolysis. By using macromolecule colloidal medium, prepared erythrocyte washing solution can make the erythrocytes break away from the hypertonic condition so that the erythrocytes are not in severe hemolytic condition. Then the macromolecular substances are washed away by normal saline, and erythrocyte saline suspension is obtained. When the technique is applied in relevant experiments, the total frozen preservation process lasts about one minute, while the unfreezing and washing processes last about fifteen minutes. Thus, the achievement rate of the erythrocytes is high.

The invention provides a circulating tumor cell dyeing kit and a use thereof. The circulating tumor cell dyeing kit is suitable for the field of biotechnology and the medical science. The circulating tumor cell dyeing kit comprises a filter, a basophilic dyeing liquid, an eosinophilic dyeing liquid, an isotonic solution and a stationary liquid, wherein the basophilic dyeing liquid, the eosinophilic dyeing liquid, the isotonic solution and the stationary liquid are sub-packaged. The filter comprises a filter membrane having aperture sizes of 8 micrometers. The basophilic dyeing liquid is an eosin Y methanol solution. The eosinophilic dyeing liquid is a phosphate buffer solution containing methlene blue and an azure I. The stationary liquid is a phosphate buffer solution containing paraformaldehyde and bovine serum albumin. The circulating tumor cell dyeing kit has good dying effects, a low cost and short operation time, can be prepared simply, is convenient for operation and greatly improves work efficiency.

This invention provides a gas bubble-generating agent that can be used as a contrast medium or a blocking agent in vivo. Such gas bubble-generating agent is produced by a method for producing a gas bubble-generating agent comprising the following steps of: (a) preparing a mixed solution of an amphiphilic substance, an amphiphilic substance comprising a water-soluble polymer chemically bound thereto, a hardly water-soluble substance having a boiling point of lower than 60° C. at atmospheric pressure, and a physiologically acceptable isotonic solution; (b) pressurizing the mixed solution; and (c) centrifuging the mixed solution after the step of pressurization, wherein a molar concentration of the amphiphilic substance in the mixed solution prepared in step (a) is 10 times or more higher than that of the amphiphilic substance comprising a water-soluble polymer chemically bound thereto.

The invention relates to collagen eye drops and a preparation method thereof. The type of the conventional antifatigue eye drops is mainly divided into a type of ocular tissue similar objects and a type of traditional Chinese medicines, the main raw material of the eye drops in type of the ocular tissue similar objects is sodium hyaluronate which has large molecular weight and is not easy to be absorbed; and the eye drops in type of the traditional Chinese medicines has bad histocompatibility with human eyes, and generates a stimulation effect on the eyes when used for a long time. The collagen eye drops disclosed by the invention is prepared by adding auxiliary materials, such as a retina growth facilitating auxiliary material, a vitamin auxiliary material, an angiotonics auxiliary material, an antihistamine auxiliary material and a preservative auxiliary material, to collagen and an isotonic solution. The collagen eye drops has excellent biological functions, high adhesivity and hydrophily, and can play the roles of supporting and lubricating during cell migration; meanwhile, various necessary elements required by the eyes can be met, the surviving environment of ocular cells can be improved, and the metabolism of the eyes can be facilitated, and the purpose of nutrition is realized; in addition, the collagen eye drops has excellent moistening and lubricating curative effects and also has excellent curative effects on xerophthalmus and asthenopia.

The invention relates to a determining method for the erythrocyte osmotic brittleness. It adopts turbidimetric analytic method as below: mixing the blood sample with the hypotonic solution with specific osmotic pressure, taking the undissolved erythrocyte as the main particle forming the turbidity of the mixed solution., selecting a undissolved erythrocyte which has higher absorbency to it, taking the specific wave length that the soluble coloured substance such as the free hemoglobin which is dissolved from erythrocyte have a weaker absorbency to it as the determining wave length, making turbidimetric analysis on the spectrophotometer: calculating the value of the haemolytic rate which is in direct ratio with the erythrocyte osmotic brittleness by comparing the different absorbency of erythrocyte in different duration of time and on the same determining condition within the hypotonic solution with the said specific osmotic pressure, or by comparing the different absorbency of erythrocyte between in the isotonic solution and in the above said hypotonic solution with specific osmotic pressure. The invention has the advantages of high accuracy, good repeatability of measurement, simple procedure, high velocity of determination, capability of realizing the dynamic determination and the full automatic analysis easily.

The invention discloses a blood cell separation method for portunus trituberculatus. The method comprises the following steps: diluting iodixanol with an isotonic solution obtained by regulating an osmotic pressure of a PBS buffer solution by utilizing a sodium chloride solution, and performing gradient preparation to obtain three iodixanol solutions of different concentrations; forming gradient solutions of different densities by adopting a cushion technology, and standing to form a continuous density gradient solution to serve as a cell separation solution; collecting blood cells of portunustrituberculatus, and taking mixed cell suspension obtained by diluting the isotonic solution; slowly dropping the mixed cell suspension into the cell separation solution, centrifuging, and dividing the blood cells of portunus trituberculatus into three layers, wherein the uppermost layer refers to clear cells, the intermediate layer refers to small granular cells, and the lowest layer refers to large granular cells. The method has the advantages that only one-step density gradient centrifugation is adopted, the operation is simple, and experiments discover that the separated blood cells haveexcellent viabilities and can be used for cell culture.

Methods for preventing a tissue infection associated with the site of a tissue disruption, such as a surgical incision. The methods include contacting tissue at the site with a composition comprising ε-polylysine in a physiologically-acceptable carrier, such as an isotonic solution, powder or hemostatic material containing ε-polylysine. Also provided are kits for preparing antibacterial ε-polylysine compositions.

A process of preparing a stable parenteral solution of a 1,4-dihydropyridine salt, such as nicardipine hydrochloride, in an acidic aqueous medium. The presence of L-arginine in the solution enhances the solubility of the salt, which is poorly soluble in water.

An aqueous, injectable isotonic solution at pH about 3.5-3.6 consists essentially of nicardipine hydrochloride, L-arginine, and a sugar alcohol.

An improved single pot manufacturing process for obtaining unsymmetrical 1,4-dihydropyridines by using more than one mole equivalent of aldehyde with respect to the other reactants (amino crotonate and acetoacetate ester). The reaction can be conducted in a solvent present at 20 times the amount of any one component.

A process for changing one polymorph of nicardipine hydrochloride (Form A) into another (Form B), and a separate process for the reverse (Form B into Form A).